Zou Q - Search Results

1

Development and initial validation of the Psoriatic Arthritis Screening Questionnaire: a cross-sectional study in Chinese population.

Zou Q, Li M, Luo Y, Chen Z, Chen J, Wang Y, Hao D, Li W. Zou Q, et al. Arch Dermatol Res. 2024 Jan 11;316(2):71. doi: 10.1007/s00403-023-02811-2. Arch Dermatol Res. 2024. PMID: 38206478 No abstract available.

2

Systemic and topical treatments for autoimmune bullous disease: A network meta-analysis of randomized controlled trials.

Hao D, Zhang Z, Zhou X, Zou Q, Wang M, Chen Z, Li W. Hao D, et al. Among authors: zou q. Chin Med J (Engl). 2025 Jan 17. doi: 10.1097/CM9.0000000000003446. Online ahead of print. Chin Med J (Engl). 2025. PMID: 39820170 No abstract available.

3

[Osteoporosis Screening Values of Osteoporosis Self-Assessment Tool for Asians Index and Body Mass Index in Middle-Aged and Elderly Tibetan Population in Tibet].

Wang P, Xiong H, Zhang YF, Wu CX, Chen T, Zou Q, Gesangpingcuo, He XY. Wang P, et al. Among authors: zou q. Sichuan Da Xue Xue Bao Yi Xue Ban. 2023 Mar;54(2):357-360. doi: 10.12182/20230360108. Sichuan Da Xue Xue Bao Yi Xue Ban. 2023. PMID: 36949698 Free PMC article. Chinese.

4

A Single-dose, Two-Period Crossover Bioequivalence Study Comparing Two Liraglutide Formulations in Healthy Chinese Subjects.

Feng S, Cai L, Wang X, Yu Q, Cai J, Hao W, Chen Z, Su X, Du C, Zou Q, Guo W, Du D, Hu F, Li F, Liu Y. Feng S, et al. Among authors: zou q. Clin Pharmacol Drug Dev. 2023 Apr;12(4):385-391. doi: 10.1002/cpdd.1187. Epub 2023 Jan 17. Clin Pharmacol Drug Dev. 2023. PMID: 36648126 Clinical Trial.

5

A phase I, single-sequence, open-label study to evaluate the drug-drug interaction between hetrombopag and cyclosporine in healthy Chinese subjects.

Li F, Lin H, Feng S, Cai L, Zhang L, Feng S, Liu X, Chen Z, Zou Q, Wu Y, Su X, Shen K, Yu Q. Li F, et al. Among authors: zou q. Br J Clin Pharmacol. 2023 Jul;89(7):2160-2167. doi: 10.1111/bcp.15664. Epub 2023 Feb 20. Br J Clin Pharmacol. 2023. PMID: 36654488 Free article. Clinical Trial.

6

Identify potential drug candidates within a high-quality compound search space.

Ru X, Zhao S, Zou Q, Xu L. Ru X, et al. Among authors: zou q. Brief Bioinform. 2024 Nov 22;26(1):bbaf024. doi: 10.1093/bib/bbaf024. Brief Bioinform. 2024. PMID: 39853109

7

Short-Term Effect of Air Pollution on Daily Hospital Visits for Anxiety Disorders in Southern China with Low Pollution Concentrations.

Zhong X, Guo T, Zhang J, Wang Q, Yin R, Wu K, Zou Q, Zheng M, Hall BJ, Renzaho AMN, Huang K, Chen W. Zhong X, et al. Among authors: zou q. Toxics. 2025 Jan 9;13(1):45. doi: 10.3390/toxics13010045. Toxics. 2025. PMID: 39853043

8

Effects of different microfracture drilling parameters on bone quality: a finite element analysis.

Luo J, Zou Z, Zou Q, Luo S, He J, Ye C. Luo J, et al. Among authors: zou q. Front Bioeng Biotechnol. 2025 Jan 8;12:1515136. doi: 10.3389/fbioe.2024.1515136. eCollection 2024. Front Bioeng Biotechnol. 2025. PMID: 39845370 Free PMC article.

9

TargetCLP: clathrin proteins prediction combining transformed and evolutionary scale modeling-based multi-view features via weighted feature integration approach.

Ullah M, Akbar S, Raza A, Khan KA, Zou Q. Ullah M, et al. Among authors: zou q. Brief Bioinform. 2024 Nov 22;26(1):bbaf026. doi: 10.1093/bib/bbaf026. Brief Bioinform. 2024. PMID: 39844339 Free PMC article.

10

PROTCROWN: A Manually Curated Resource of Protein Corona Data for Unlocking the Potential of Protein-Nanoparticle Interactions.

Su Y, Fu X, Wei L, Zhang Z, Zou Q, Cui F. Su Y, et al. Among authors: zou q. Nano Lett. 2025 Jan 21. doi: 10.1021/acs.nanolett.4c05955. Online ahead of print. Nano Lett. 2025. PMID: 39836872 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

2,922 results

Search Page

Filters